Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)
6,630.00
+60.00 (0.91%)
At close: Jan 23, 2026
Daehan Nupharm Revenue
Daehan Nupharm had revenue of 48.88B KRW in the quarter ending September 30, 2025, with 0.15% growth. This brings the company's revenue in the last twelve months to 201.59B, down -0.12% year-over-year. In the year 2024, Daehan Nupharm had annual revenue of 202.19B, down -1.00%.
Revenue (ttm)
201.59B
Revenue Growth
-0.12%
P/S Ratio
0.46
Revenue / Employee
884.17M
Employees
228
Market Cap
93.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 202.19B | -2.04B | -1.00% |
| Dec 31, 2023 | 204.22B | 6.27B | 3.16% |
| Dec 31, 2022 | 197.96B | 31.37B | 18.83% |
| Dec 31, 2021 | 166.59B | 17.29B | 11.58% |
| Dec 31, 2020 | 149.29B | 15.20B | 11.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 300.96B |
| H.PIO | 257.56B |
| HYUNDAI BIOLAND | 129.68B |
| Sinsin Pharmaceutical | 110.29B |
| Hwail Pharmaceutical | 107.87B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 102.11B |
| Sam-A Pharm. | 76.66B |
| High Tech Pharm | 75.60B |